Moreover, the lower antigenic load, low tumor mutational burden, and programmed cell death ligand 1 (PD-L1) expression of non-cutaneous melanomas together with a higher level of aneuploidy might be associated with lower T cell activation and poor response to immunotherapy [12,29]. This evidence concerns the gene CD274 and neoplasm.